ReviewEndocrinology, diabetes & metabolism2026
Comparative Efficacy and Safety of Resmetirom and Efruxifermin for Metabolic Dysfunction-Associated Steatohepatitis: A Network Meta-Analysis of Randomized Controlled Trials.
Doha Jaber et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.